<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Structural Molecular Biology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/E75B28C8-BBD5-4823-9BE5-C970FC67D2C1"><gtr:id>E75B28C8-BBD5-4823-9BE5-C970FC67D2C1</gtr:id><gtr:firstName>Emmanuel</gtr:firstName><gtr:surname>Boucrot</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FI018921%2F1"><gtr:id>B93D0813-5A21-4731-B61B-D3BBD703440B</gtr:id><gtr:title>Regulation of membrane trafficking by phoshorylation during cell division.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>BB/I018921/1</gtr:grantReference><gtr:abstractText>Each one of the several billions cells composing our body must divide to multiply during growth, healing or normal regeneration. Cell division is a complex event during which many of the processes happening inside each cell must be tightly controlled. For successful cell division to happen, some cellular events must be activated and others inhibited. Failure of certain key steps can lead to growth defects and anomalies and to various diseases such as cancer. The research I intend to perform aims at understanding how cells control the exchanges of their membrane between their envelope and interior. It is a very important aspect of cell division as it can, if perturbed, compromise proper cell renewal. Acquiring a global understanding of these events is desirable in order to progress in our knowledge of how cells function and to have the material to design new therapies for treating some related human diseases.</gtr:abstractText><gtr:technicalSummary>Reversible phosphorylation controls most cellular processes, including cell division. Membrane trafficking is an emerging feature of cell division. I aim at identifying key proteins regulating membrane trafficking during cell division and at dissecting how phosphorylation potentially regulates them. Because membrane trafficking and cell division are two complex processes involving a number of proteins, I propose to study these systems in a global manner so as to gain a more complete understanding of their mechanisms. We will combine phospho-proteomics, high-throughput screening microscopy with classical biochemistry and cell biology assays that I used in my past studies to dissect the global mechanisms of phospho-regulation of membrane trafficking during cell division. These studies are expected to contribute to our global understanding of the regulation of cellular membrane exchanges and cell division.</gtr:technicalSummary><gtr:potentialImpactText>My research aims at understanding an important process involved in cell division and renewal. Each one of the several billions cells composing our body must divide to multiply during growth, healing or normal regeneration. Defects in such process lead to various pathologic conditions such as growth and development defects or chronic diseases, especially cancer. Progresses in the global knowledge of how cells regenerate by division will be beneficial to persons concerned by the aforementioned diseases and to pharmaceutical companies that aim at finding cures to such diseases.</gtr:potentialImpactText><gtr:fund><gtr:end>2016-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2011-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1225847</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Hosting Year 12 students for their first lab experience</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>5E83E550-A4F6-4014-811F-516EE30ED932</gtr:id><gtr:impact>The students were very happy to get to have their first 'hands-on' laboratory experiences.

The students said that they would consider choosing medical research in their future studies.</gtr:impact><gtr:outcomeId>545bd9d1da7c58.33860450</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012,2013,2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Hosting student cohorts part of Sutton Trust Biosciences Summer School to introduce our research</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>EB521375-C202-4373-91F6-C95BC99D3DCD</gtr:id><gtr:impact>Hosting student cohorts part of Sutton Trust Biosciences Summer School to introduce our research

After their visits, several students decided to pursuit their interest in science and to choose Biochemistry at University</gtr:impact><gtr:outcomeId>569d3167829fa5.05576521</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012,2013,2014,2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>2014 Lister Institute Research Prize</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Lister Institute of Preventive Medicine</gtr:fundingOrg><gtr:id>471DDBFA-6534-4F66-9534-0E4BCA02A9FD</gtr:id><gtr:outcomeId>545bd8d8577a27.77072830</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>108228</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship</gtr:description><gtr:end>2017-08-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>FS/14/20/30681</gtr:fundingRef><gtr:id>07BDE953-61B7-4420-8067-10CE466BDA5B</gtr:id><gtr:outcomeId>569d2c55421d44.43646224</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>514066</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2018-05-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/M009203/1</gtr:fundingRef><gtr:id>7F5DFC38-124F-4A08-BAF8-FD8645B02A47</gtr:id><gtr:outcomeId>569d2bd926cd45.42909870</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>- we found that clathrin-mediated endocytosis is greatly reduced but some other portals of entry in cells are more active in G0, quiescent cells. We are currently investigating the molecular mechanism as part of follow-up project funded by the British Heart Foundation. 

- we identified the first specific G0 markers (there are no specific markers to identify quiescent cells so far, see Coller HA Science 2011). In addition, we revealed the molecular basis for resistance to cell death during cell quiescence. We demonstrated that the extracellular matrix is dictating cell cycle arrest and pro-survival signaling, events that are highly relevant to long-term survival of adult stem stems in specific niches (where the extracellular matrix we identified is enriched). 

- we performed 2 quantitative mass spectrometry screens to measure protein and phosphorylation levels in i) cells isolated at each stage of the cell cycle (G1, S, G2 and M) using a novel technique I developed that alleviates the need for drugs to synchronise cells (which induce artifactual phosphorylations) and ii) in quiescent cells (also called the G0 phase of the cell cycle). We acquired high quality quantitative information on 8,377 proteins and 15,068 unique phosphorylation sites along the cell cycle. These studies provide an unparalleled resource to dissect the changes in protein and phosphorylation levels all along the cell cycle of human cells. 

- we found that the bacterium Salmonella block the cell division of their host cells (Santos et al. Infect Immun 2016). In infected mice, proliferation of small intestinal epithelial cells was compromised, suggesting that cytokinesis failure caused by S Typhimurium delays epithelial cell turnover in the intestine.

- we discovered that the bacterium Salmonella infects preferably cells when they divide (Santos et al. J Cell Sci 2013). This might explain why certain bacteria are so efficient at targeting and infecting solid tumours. Several biotechnology companies are using this characteristic to improve the drug delivery to resilient tumours.

- we revealed that stalling cells during mitosis using drug treatment perturbs they capacity to internalise nutrients and cell surface proteins (Tacheva et al. Cell Reports 2013). This work might inform the design of new anti-cancer treatments.

- we discovered a new pathway of endocytosis, i.e. a new portal of entry into cells (Boucrot et al. Nature 2015; Renard et al. Nature 2015). One important particularity of this pathway is that it is not constitutive (i.e. it is inactive in resting cells) and only the stimulation of specific receptors with their cognate ligands triggers the rapid formation of endocytic carriers. This characteristic makes it a prime candidate for future therapeutic manipulation and drug targeting.</gtr:description><gtr:exploitationPathways>- we discovered that the bacterium Salmonella infects preferably cells when they divide (Santos et al. J Cell Sci 2013). This might explain why certain bacteria are so efficient at targeting and infecting solid tumours. Several biotechnology companies are using this characteristic to improve the drug delivery to resilient tumours.

- we revealed that stalling cells during mitosis using drug treatment perturbs they capacity to internalise nutrients and cell surface proteins (Tacheva et al. Cell Reports 2013). This work might inform the design of new anti-cancer treatments.

- we discovered a new pathway of endocytosis, i.e. a new portal of entry into cells (Boucrot et al. Nature 2015; Renard et al. Nature 2015). One important particularity of this pathway is that it is not constitutive (i.e. it is inactive in resting cells) and only the stimulation of specific receptors with their cognate ligands triggers the rapid formation of endocytic carriers. This characteristic makes it a prime candidate for future therapeutic manipulation and drug targeting.</gtr:exploitationPathways><gtr:id>9C8E528A-8566-4DDD-9A03-A1E6AAE71CCD</gtr:id><gtr:outcomeId>545c8e5616ec49.89974784</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>FB4DEBE2-B453-49A8-9217-7C5815815B68</gtr:id><gtr:title>Clathrin-mediated endocytosis persists during unperturbed mitosis.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93c5773dbd5964ce7c16d5474458423d"><gtr:id>93c5773dbd5964ce7c16d5474458423d</gtr:id><gtr:otherNames>Tacheva-Grigorova SK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>pm_5435b085b08ca38eb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05154B74-91C9-4EF9-A75F-A658932D208A</gtr:id><gtr:title>Membrane curvature at a glance.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f52a0927631a68bcb1bda16bf0910b5"><gtr:id>3f52a0927631a68bcb1bda16bf0910b5</gtr:id><gtr:otherNames>McMahon HT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>569d2ab433b8e6.70796769</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43CF60F1-1B77-439C-82BF-ECB9296DABD4</gtr:id><gtr:title>Endophilin marks and controls a clathrin-independent endocytic pathway.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5d9540b814df068576a05b1df1bd6ff"><gtr:id>b5d9540b814df068576a05b1df1bd6ff</gtr:id><gtr:otherNames>Boucrot E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>569d29514192c8.75119974</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>915FE454-78FC-4C5F-8D8E-E94C6C10EABE</gtr:id><gtr:title>Preferential invasion of mitotic cells by Salmonella reveals that cell surface cholesterol is maximal during metaphase.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eaaea4621b65e2a1bf568a8f0ad987ea"><gtr:id>eaaea4621b65e2a1bf568a8f0ad987ea</gtr:id><gtr:otherNames>Santos AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>569d28ba621521.59906315</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EADF1C93-1C9B-44E0-85AA-894FD0E1B8D9</gtr:id><gtr:title>Endophilin-A2 functions in membrane scission in clathrin-independent endocytosis.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64a818f5c5fd889cc28ba76f20b29a78"><gtr:id>64a818f5c5fd889cc28ba76f20b29a78</gtr:id><gtr:otherNames>Renard HF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>569d2a42a05dc0.16296130</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EA65CF0-32FE-40A6-ACCB-6610F6E24968</gtr:id><gtr:title>Clustered Intracellular Salmonella enterica Serovar Typhimurium Blocks Host Cell Cytokinesis.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eaaea4621b65e2a1bf568a8f0ad987ea"><gtr:id>eaaea4621b65e2a1bf568a8f0ad987ea</gtr:id><gtr:otherNames>Santos AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>58c7b6b9545f83.16826585</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/I018921/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>